chr1-109716394-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000851.4(GSTM5):​c.568-943G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 157,092 control chromosomes in the GnomAD database, including 8,494 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 8156 hom., cov: 33)
Exomes 𝑓: 0.36 ( 338 hom. )

Consequence

GSTM5
NM_000851.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0170

Publications

10 publications found
Variant links:
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.681 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000851.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSTM5
NM_000851.4
MANE Select
c.568-943G>T
intron
N/ANP_000842.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSTM5
ENST00000256593.8
TSL:1 MANE Select
c.568-943G>T
intron
N/AENSP00000256593.3P46439
GSTM5
ENST00000878690.1
c.646-943G>T
intron
N/AENSP00000548749.1
GSTM5
ENST00000966870.1
c.646-943G>T
intron
N/AENSP00000636929.1

Frequencies

GnomAD3 genomes
AF:
0.296
AC:
44983
AN:
152088
Hom.:
8151
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.112
Gnomad AMI
AF:
0.190
Gnomad AMR
AF:
0.375
Gnomad ASJ
AF:
0.363
Gnomad EAS
AF:
0.701
Gnomad SAS
AF:
0.453
Gnomad FIN
AF:
0.343
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.338
Gnomad OTH
AF:
0.313
GnomAD4 exome
AF:
0.358
AC:
1748
AN:
4886
Hom.:
338
Cov.:
0
AF XY:
0.374
AC XY:
996
AN XY:
2662
show subpopulations
African (AFR)
AF:
0.0469
AC:
3
AN:
64
American (AMR)
AF:
0.445
AC:
73
AN:
164
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
34
AN:
102
East Asian (EAS)
AF:
0.595
AC:
44
AN:
74
South Asian (SAS)
AF:
0.472
AC:
154
AN:
326
European-Finnish (FIN)
AF:
0.347
AC:
66
AN:
190
Middle Eastern (MID)
AF:
0.455
AC:
10
AN:
22
European-Non Finnish (NFE)
AF:
0.346
AC:
1277
AN:
3690
Other (OTH)
AF:
0.343
AC:
87
AN:
254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
59
117
176
234
293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.296
AC:
45014
AN:
152206
Hom.:
8156
Cov.:
33
AF XY:
0.299
AC XY:
22267
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.113
AC:
4685
AN:
41552
American (AMR)
AF:
0.374
AC:
5725
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
1260
AN:
3468
East Asian (EAS)
AF:
0.700
AC:
3619
AN:
5172
South Asian (SAS)
AF:
0.454
AC:
2188
AN:
4822
European-Finnish (FIN)
AF:
0.343
AC:
3639
AN:
10596
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.338
AC:
22957
AN:
67992
Other (OTH)
AF:
0.318
AC:
671
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1462
2923
4385
5846
7308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.297
Hom.:
949
Bravo
AF:
0.291
Asia WGS
AF:
0.510
AC:
1771
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.3
DANN
Benign
0.51
PhyloP100
0.017
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3768490; hg19: chr1-110259016; COSMIC: COSV56657110; API